Evidence map›Paper›PMID 42789089›Full record

ArticleActa neuropathologica2026

Integrative synaptosome multi-omics reveals disrupted synapse organization and localized cryptic transcripts in C9ORF72-frontotemporal dementia.

Ashton M Spillman, Eric B Alsop, Lauren M Gittings, Krystine Garcia-Mansfield, Ignazio Piras, Anna Bonfitto, Melissa N Martinez, Ritin Sharma, Kim R Preller, Matthew Huentelman and 3 more

Abstract read
In one paragraph

Article in Acta neuropathologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Ashton M SpillmanDepartment of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ, USA.
Eric B AlsopBioinnovation and Genome Sciences, Translational Genomics Research Institute, Phoenix, AZ, USA.
Lauren M GittingsDepartment of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ, USA.
Krystine Garcia-MansfieldEarly Detection and Prevention, Translational Genomics Research Institute, Phoenix, AZ, USA.
Ignazio PirasBioinnovation and Genome Sciences, Translational Genomics Research Institute, Phoenix, AZ, USA.
Anna BonfittoBioinnovation and Genome Sciences, Translational Genomics Research Institute, Phoenix, AZ, USA.
Melissa N MartinezEarly Detection and Prevention, Translational Genomics Research Institute, Phoenix, AZ, USA.
Ritin SharmaEarly Detection and Prevention, Translational Genomics Research Institute, Phoenix, AZ, USA.
Kim R PrellerDepartment of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ, USA.
Matthew HuentelmanBioinnovation and Genome Sciences, Translational Genomics Research Institute, Phoenix, AZ, USA.
Patrick Pirrotte *Early Detection and Prevention, Translational Genomics Research Institute, Phoenix, AZ, USA.
Kendall Van Keuren-Jensen *Bioinnovation and Genome Sciences, Translational Genomics Research Institute, Phoenix, AZ, USA.
Rita Sattler *Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ, USA. Rita.sattler@barrowneuro.org.

Funding

The role of an aberrant synaptome in microglia-associated synaptic pruning in C9orf72-FTDR01NS120331 · NINDS · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI SATTLER, RITA, VAN KEUREN-JENSEN, KENDALL R · 2021 to 2025
$4.2M
Arizona Department of Health Services CTR057001NINDS NIH HHS R01 NS120331NINDS NIH HHS R01NS120331
6 · The paper itself

Abstract

Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are linked neurodegenerative diseases characterized by both synaptic dysfunction and TDP-43 pathology. A hexanucleotide repeat expansion (HRE) in the C9ORF72 (C9) gene represents the most common genetic cause of FTD and ALS, yet the synapse-specific mechanisms underlying disease pathogenesis remain poorly understood. Here, we performed integrated multi-omic profiling of synaptosomes enriched from postmortem frontal cortex and patient-derived induced pluripotent stem cell (iPSC)-cortical neurons to define molecular alterations associated with C9-FTD-mediated synaptic dysfunction. Proteomic profiling of frontal cortex-derived synaptosomes identified 1,324 differentially abundant proteins (p<0.05) enriched in pathways regulating synaptic vesicle transport and synapse organization, while synaptosomal RNA sequencing revealed 2,835 differentially expressed protein-coding genes. C9-FTD iPSC-cortical neurons exhibited reductions in excitatory and inhibitory postsynaptic markers, accompanied by progressive impairment of neuronal network activity, supporting both structural and functional deficits. iPSC-derived synaptosomes recapitulated key molecular pathways observed in patient brain, revealing convergent dysregulation of synaptic signaling pathways. Comparative analyses revealed divergence between protein and RNA alterations, consistent with the disruption of regulatory processes that link RNA and protein abundance in diseased synapses. Consistent with TDP-43 loss-of-function pathology we identified cryptic exon (CE)-containing transcripts within C9-FTD frontal cortex-derived synaptosomes, including KALRN and STMN2, providing evidence that aberrantly spliced RNAs localize to synaptic compartments. Together, these findings define convergent molecular pathways underlying synapse vulnerability in both C9-FTD model systems and identify synaptic localization of CE-containing transcripts as a previously unrecognized feature of TDP-43 proteinopathy.

Indexed as

C9orf72 ProteinFrontotemporal DementiaSynapsesSynaptosomesFemaleFrontal LobeHumansInduced Pluripotent Stem CellsMaleMultiomicsNeuronsProteomicsC9orf72 ProteinC9orf72 protein, humanCryptic Exon (CE)Frontotemporal Dementia (FTD)ProteomicsSynaptosomeTAR DNA-binding protein 43 (TDP-43)Transcriptomics

Identifiers

PMID42789089
PMCPMC13615078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.